. 2021 Jan 5;5(1):1–18. doi: 10.15698/cst2021.01.239
Copyright: © 2021 Shen et al.
This is an open-access article released under the terms of the Creative Commons Attribution (CC BY) license, which allows the unrestricted use, distribution, and reproduction in any medium, provided the original author and source are acknowledged.
This is an open-access article released under the terms of the Creative Commons Attribution (CC BY) license, which allows the unrestricted use, distribution, and reproduction in any medium, provided the original author and source are acknowledged.
Figure 7. FIGURE 7: FXR and TGR5 dual targeting agonists and other dual targeting compounds.
